-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Tyra Biosciences, Raises Price Target to $37

Benzinga·12/16/2025 12:36:19
語音播報
Wedbush analyst Robert Driscoll maintains Tyra Biosciences (NASDAQ:TYRA) with a Outperform and raises the price target from $30 to $37.